Literature DB >> 10638665

Magnolol attenuates peroxidative damage and improves survival of rats with sepsis.

C W Kong1, K Tsai, J H Chin, W L Chan, C Y Hong.   

Abstract

Reactive oxygen species and peroxidative damage are implicated in the pathophysiology of sepsis. Magnolol is a compound extracted from the Chinese medicinal herb Magnolia officinalis and has multiple pharmacological effects, notably antioxidant functions. To determine whether magnolol can modulate the course of sepsis, survival rate and biochemical parameters were analyzed in rats with sepsis with various treatment protocols. Magnolol at doses ranging from 10(-9) g/kg to 10(-5) g/kg was administered either before or after induction of sepsis by cecal ligation and puncture. Magnolol did not modulate the course of sepsis induced by two cecal punctures. When one cecal puncture was performed, a moderately evolving type of sepsis was induced, and the survival rate of affected rats was significantly improved by pretreatment with 10(-7) g/kg magnolol. The beneficial effect was partially retained if magnolol was administered 6 hours after onset of sepsis when a higher dose (10(-5) g/kg) was used. The intensity of lipid peroxidation in plasma, liver, and lung of septic rats was also attenuated in a treatment-dependent manner. Magnolol at this dose range exerted these beneficial effects probably through its antioxidant efficacy. These significant results may suggest magnolol as a candidate agent for the treatment of sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638665     DOI: 10.1097/00024382-200013010-00005

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  20 in total

1.  Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function.

Authors:  Eun Mi Choi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

2.  Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.

Authors:  S-N Wu; C-C Chen; H-F Li; Y-K Lo; S-A Chen; H-T Chiang
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Yun Feng Ni; Tao Jiang; Qing Shu Cheng; Zhong Ping Gu; Yi Fang Zhu; Zhi Pei Zhang; Jian Wang; Xiao Long Yan; Wu Ping Wang; Chang Kang Ke; Yong Han; Xiao Fei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  Magnolol reduces bleomycin-induced rodent lung fibrosis.

Authors:  Xiangfeng Zhang; Han Huang; Huijuan Chang; Xiuhong Jin
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation.

Authors:  Cristiane Ritter; Michael Andrades; Mário Luis C Frota Júnior; Fernanda Bonatto; Ricardo A Pinho; Manuela Polydoro; Fábio Klamt; Cleovaldo T S Pinheiro; Sérgio S Menna-Barreto; José Cláudio F Moreira; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2003-05-29       Impact factor: 17.440

6.  Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators.

Authors:  Tie-Cheng Yang; Shu-Wen Zhang; Li-Na Sun; Hong Wang; Ai-Min Ren
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

7.  Magnolol pretreatment attenuates heat stress-induced IEC-6 cell injury.

Authors:  Chen Mei; Sha-Sha He; Peng Yin; Lei Xu; Ya-Ran Shi; Xiao-Hong Yu; An Lyu; Feng-Hua Liu; Lin-Shu Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2016-06       Impact factor: 3.066

8.  Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells.

Authors:  Shih-Chung Chen; Ying-Ling Chang; Danny Ling Wang; Jing-Jy Cheng
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

9.  Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.

Authors:  Shu-Er Yang; Ming-Tsuen Hsieh; Tung-Hu Tsai; Shih-Lan Hsu
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2012-07-31       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.